مركز العلاج الخلوي المتقدم

The Advanced Cell Therapy Core (ACTC) synergistically completes Sidra Medicine’s Precision Medicine Program to provide personalized treatments to patients. The ACTC is designed to provide advanced personalized care in a patient’s path from diagnosis to intervention by tailoring treatment options in the fields of:

• Hematopoietic Stem Cell (HSC) Transplantation, e.g. processing of HSC
• Cell Therapy, e.g. production of third party Mesenchymal Stromal Cells (MSC) as off-the-shelf treatment for several clinical applications
• Regenerative Medicine, e.g. production of platelets derivatives
• Gene Therapy, e.g. replacement of a faulty gene

These treatments promise to reverse often debilitating manifestations of diseases – such as cancer, genetic and metabolic disorders – that disproportionately affect children, as well as provide opportunities for therapies using stem cells for rejuvenation and regeneration in pediatric and maternal care.